Telmisartan and Rosuvastatin Tablets 80/10 mg

Adult dose

Telmisartan: For essential hypertension, the recommended oral dose is 40 mg once daily; 20 mg once daily may be effective for some patients. It can be increased to a maximum of 80 mg once daily if necessary. For the purpose of reducing cardiovascular disease risk, the recommended oral dose is 80 mg once daily. Patients with liver impairment should not exceed 40 mg once daily. Rosuvastatin Calcium: The initial dose is 5 mg once daily.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Women of childbearing potential must use appropriate contraceptive methods before taking this medication, and it should not be used during pregnancy or breastfeeding. Patients who are allergic to any ingredients in this medication or those with severely impaired liver and kidney function or certain genetic disorders should not receive this medication. Special caution is required for the elderly, patients with hyperkalemia, and those with liver impairments, and regular monitoring of liver function and muscle status should be conducted. If symptoms like muscle pain, muscle weakness, dizziness, or severe fatigue occur, consult a physician immediately and consider stopping the medication in severe cases. This medication may interact with other drugs; thus, if you are taking other medications, you must inform your doctor or pharmacist, especially regarding blood pressure medications, diuretics, and anticoagulants. Symptoms such as hypotension, dizziness, and acute renal failure may occur in case of overdose; immediate emergency treatment should be sought. Caution is advised when driving or operating machines as dizziness or drowsiness may occur. The safety and efficacy of this medication have not been established in children, and its use is not recommended. When storing, keep it out of reach of children and do not transfer to another container.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin shedding, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination abnormalities

Mild side effects

• Dyspepsia
• oral dysesthesia
• musculoskeletal stiffness
• acne
• itching
• dizziness
• nasopharyngitis
• dysuria
• rhinitis
• discomfort in the oropharynx

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. Doing so helps preserve the medication's effectiveness and safety over time.

Appearance

Pale orange oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTPX3]